Study shows oral semaglutide matches DPP-4i in adherence and persistence for type 2 diabetes

FHS
July 16, 2024
4:33 am

Researchers found that adherence and persistence in T2D patients using oral semaglutide is similar to DPP-4i, but semaglutide users required fewer concurrent medications, indicating higher long-term efficacy.

Exclusive: DeepMind’s Demis Hassabis unveils his vision for Isomorphic and AI’s future in biotech

While Demis Hassabis is best known for steering Alphabet’s research efforts in artificial intelligence, the 47-year-old is simultaneously leading a secretive biotech startup looking to

September 27, 2023

shareholders approved all motions at today’s AGM 2023 – Biotech Investments

Xlife Sciences AG / Key word(s): AGMEGM Media Release Zurich, June 20, 2023 Xlife Sciences: shareholders approved all motions at today’s AGM 2023 20.06.2023 /

June 21, 2023

Beckman Coulter Life Sciences and Pillar Biosciences announce NGS application development pipeline for the Biomek NGeniuS System

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, continues to lead the way with next-generation sequencing (NGS) research solutions. Today the

November 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.